Series “Reading 2025 Layoffs”: The Funding Climate: How Selectivity Works Across VC, Public, Debt, and M&A (Part 4)
Category: Pharma & Biotech NEWS | Series “Reading 2025 Layoffs” — Part 4 Key Takeaways Capital concentrates near POC: late-stage/near-commercial assets attract flows; discovery–preclinical is tightly screened; non-dilutive capital br...
